InterCare DX, Inc. (ICCO)
Torrance, CA, US
InterCare DX, Inc. operates as a biomedical and other software products development and services company. It creates, publishes, and markets software products that are embedded with sound, text, and video for relaxation training and stress management. The company also develops an integrated Internet-ready and RFID enabled applications, which target education, hospitality, legal system, human capital, and healthcare industry markets. Its products comprise e-Learning Integrated Technology Enterprise Systems for integrated tuition, boarding and lodging management, enterprise vendor portal, customer relationship management, enterprise budgeting, and financial management, as well as other tools used in administering education at all levels; InterCare Clinical Explorer, a software application designed to integrate virtually all aspects of the healthcare enterprise; and InterCare Vascular Diagnostic Center to measure vascular health in patients before exhibiting symptoms. The company was formerly known as InterCare Diagnostics. InterCare DX, Inc. was founded in 1991 and is based in Hawthorne, California. InterCare DX, Inc.is a subsidiary of Meridian Holdings, Inc.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | -97.22% | -99.64% | -99.42% | -96.67% | -90.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Software - Application: +13.0%—
-
EPS growth Software - Application: +28.6%-22.4% Q2'23: -8.7% (vs Q2'22)
-
FCF margin FCF growth · Software - Application: +45.3%—
-
EBIT margin Software - Application: +9.4%—
-
ROIC Software - Application: +7.5%— Q2'23: +0.0% (vs Q2'22)
-
Share dilution Software - Application: +0.0%+0.0% Q2'23: +0.0% (vs Q2'22)
-
Debt / EBITDA Net debt/EBITDA · Software - Application: -1.16×—
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Russ A. Lyon | Chief Technology Officer | 200.0K | male |
| Anthony C. Dike | Founder, Chairman, Chief Executive Officer, Chief Financial Officer, Secretary, Treasurer and Member of the Clinical Advisory Board | — | — |
| Donald L. Stanford | Chief Technical Strategist and Director | — | male |
| Jerry Miller | Interim President and Interim Chief Operations Officer | — | male |
| Kenneth Johnson | Vice President of Business Development and Vice President of Finance | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ICCO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
